Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation.

Joshi D, Salehi S, Brereton H, Arno M, Quaglia A, Heaton N, O'Grady J, Agarwal K, Aluvihare V.

Liver Transpl. 2013 Apr;19(4):383-94. doi: 10.1002/lt.23613. Epub 2013 Mar 22.

2.

Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.

Grassi A, Ballardini G.

World J Gastroenterol. 2014 Aug 28;20(32):11095-115. doi: 10.3748/wjg.v20.i32.11095. Review.

3.

Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future.

Dumortier J, Boillot O, Scoazec JY.

World J Gastroenterol. 2014 Aug 28;20(32):11069-79. doi: 10.3748/wjg.v20.i32.11069. Review.

4.

Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.

Thibault PA, Wilson JA.

Pharmacol Res. 2013 Sep;75:48-59. doi: 10.1016/j.phrs.2013.03.004. Epub 2013 Mar 27. Review.

PMID:
23541631
5.

Hepatitis C virus recurrence after liver transplantation: biomarkers of disease and fibrosis progression.

Maluf DG, Archer KJ, Villamil F, Stravitz RT, Mas V.

Expert Rev Gastroenterol Hepatol. 2010 Aug;4(4):445-58. doi: 10.1586/egh.10.39. Review.

PMID:
20678018
6.

Recurrent hepatitis C after liver transplant.

deLemos AS, Schmeltzer PA, Russo MW.

World J Gastroenterol. 2014 Aug 21;20(31):10668-81. doi: 10.3748/wjg.v20.i31.10668. Review.

7.

Hepatitis C.

Burra P.

Semin Liver Dis. 2009 Feb;29(1):53-65. doi: 10.1055/s-0029-1192055. Epub 2009 Feb 23. Review.

PMID:
19235659
8.

MicroRNA-mediated interactions between host and hepatitis C virus.

Li H, Jiang JD, Peng ZG.

World J Gastroenterol. 2016 Jan 28;22(4):1487-96. doi: 10.3748/wjg.v22.i4.1487. Review.

9.

Inflammatory status in human hepatic cirrhosis.

Martínez-Esparza M, Tristán-Manzano M, Ruiz-Alcaraz AJ, García-Peñarrubia P.

World J Gastroenterol. 2015 Nov 7;21(41):11522-41. doi: 10.3748/wjg.v21.i41.11522. Review.

10.

Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging.

Saludes V, González V, Planas R, Matas L, Ausina V, Martró E.

World J Gastroenterol. 2014 Apr 7;20(13):3431-42. doi: 10.3748/wjg.v20.i13.3431. Review.

11.

Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review.

Vasuri F, Malvi D, Gruppioni E, Grigioni WF, D'Errico-Grigioni A.

World J Gastroenterol. 2014 Mar 21;20(11):2810-24. doi: 10.3748/wjg.v20.i11.2810. Review.

12.

Markers of acute rejection and graft acceptance in liver transplantation.

Germani G, Rodriguez-Castro K, Russo FP, Senzolo M, Zanetto A, Ferrarese A, Burra P.

World J Gastroenterol. 2015 Jan 28;21(4):1061-8. doi: 10.3748/wjg.v21.i4.1061. Review.

13.

Noninvasive diagnosis of acute rejection of renal allografts.

Hartono C, Muthukumar T, Suthanthiran M.

Curr Opin Organ Transplant. 2010 Feb;15(1):35-41. doi: 10.1097/MOT.0b013e3283342728. Review.

14.

Modulation of immune responses following solid organ transplantation by microRNA.

Sarma NJ, Tiriveedhi V, Ramachandran S, Crippin J, Chapman W, Mohanakumar T.

Exp Mol Pathol. 2012 Dec;93(3):378-85. doi: 10.1016/j.yexmp.2012.09.020. Epub 2012 Oct 1. Review.

15.

Liver pathology of hepatitis C, beyond grading and staging of the disease.

Dhingra S, Ward SC, Thung SN.

World J Gastroenterol. 2016 Jan 28;22(4):1357-66. doi: 10.3748/wjg.v22.i4.1357. Review.

16.

Differential expression and functions of microRNAs in liver transplantation and potential use as non-invasive biomarkers.

Wei L, Gong X, Martinez OM, Krams SM.

Transpl Immunol. 2013 Dec;29(1-4):123-9. doi: 10.1016/j.trim.2013.08.005. Epub 2013 Aug 31. Review.

17.

Chronic allograft dysfunction: diagnosis and management. Is it always progressive?

Neuberger J.

Liver Transpl. 2005 Nov;(11 Suppl 2):S63-8. Review.

18.

Hepatitis C virus infection, microRNA and liver disease progression.

Shrivastava S, Mukherjee A, Ray RB.

World J Hepatol. 2013 Sep 27;5(9):479-86. doi: 10.4254/wjh.v5.i9.479. Review.

19.

The Potential of MicroRNAs as Novel Biomarkers for Transplant Rejection.

Hamdorf M, Kawakita S, Everly M.

J Immunol Res. 2017;2017:4072364. doi: 10.1155/2017/4072364. Epub 2017 Jan 16. Review.

20.

Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal.

Rodríguez-Perálvarez M, Rico-Juri JM, Tsochatzis E, Burra P, De la Mata M, Lerut J.

Transpl Int. 2016 Sep;29(9):961-73. doi: 10.1111/tri.12737. Epub 2016 Jan 29. Review.

PMID:
26714264

Supplemental Content

Support Center